David Henry Mack - May 20, 2021 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Signature
/s/ David H. Mack
Stock symbol
PMVP
Transactions as of
May 20, 2021
Transactions value $
-$491,676
Form type
4
Date filed
5/24/2021, 04:52 PM
Previous filing
Jun 8, 2021
Next filing
Jun 4, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Options Exercise $4.13K +7.79K +315.51% $0.53* 10.3K May 20, 2021 Direct
transaction PMVP Common Stock Sale -$277K -7.79K -75.93% $35.60 2.47K May 20, 2021 Direct F1, F2
transaction PMVP Common Stock Options Exercise $3.29K +6.21K +251.3% $0.53* 8.68K May 21, 2021 Direct
transaction PMVP Common Stock Sale -$222K -6.21K -71.53% $35.71 2.47K May 21, 2021 Direct F1, F3
holding PMVP Common Stock 228K May 20, 2021 See footnote F4
holding PMVP Common Stock 57K May 20, 2021 See footnote F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Stock Option (right to buy) Options Exercise $0 -7.79K -1.56% $0.00 493K May 20, 2021 Common Stock 7.79K $0.53 Direct F6
transaction PMVP Stock Option (right to buy) Options Exercise $0 -6.21K -1.26% $0.00 485K May 21, 2021 Common Stock 6.21K $0.53 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.53 to $35.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.53 to $35.99, inclusive.
F4 The shares are held of record by The Mack-Mulligan Revocable Trust, for which the Reporting Person serves as co-trustee.
F5 The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust, for which the Reporting Person serves as co-trustee.
F6 The shares subject to the option are fully vested and immediately exercisable.